CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLYGet Rating) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 4,400 shares, a drop of 48.2% from the August 15th total of 8,500 shares. Based on an average daily volume of 69,500 shares, the short-interest ratio is presently 0.1 days.

CSL Trading Up 0.0 %

Shares of CSL stock opened at $96.11 on Friday. The company’s fifty day simple moving average is $101.08 and its 200-day simple moving average is $97.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 3.43 and a current ratio of 4.94. CSL has a 1 year low of $85.07 and a 1 year high of $117.24.

CSL Company Profile

(Get Rating)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants.

See Also

Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.